COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 915: Articles 9141-9150  | Next

Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population
Bednarski, E., Del Rio Estrada, P. M., DaSilva, J., Boukadida, C., Zhang, F., Luna Villalobos, Y. A., Rodriguez Range, X., Piten Isidro, E., Luna Garcia, E., Diaz Rivera, D., Lopez Sanchez, D. M., Tapia Trejo, D., Soto-Nava, M., Astorga Castaneda, M., Martinez Moreno, J. O., Urbina Granados, G. S., Jimenez Jacinto, J. A., Serna Alvarado, F. J., Enriquez Lopez, Y. E., Lopez Arellano, O., Reyes Teran, G., Bieniasz, P. D., Avila Rios, S., Hatziioannou, T.
10.1101/2022.02.07.22270626 — Posted: 2022-02-08 Discussion: Offsite
Clinical and Economic Impact of COVID-19 on Plantation Workers: Preliminary Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study
Olson, D., Calvimontes, D. M., Lamb, M. M., Guzman, G., Barrios, E., Chacon, A., Rojop, N., Arias, K., Gomez, M., Bolanos, G. A., Monzon, J., Chard, A. N., Iwaomto, C., Duca, L. M., Vuong, N., Fineman, M., Lesteberg, K., Beckham, D., Santiago, M. L., Quicke, K., Ebel, G., Zielinski Gutierrez, E., Azziz-Baumgartner, E., Hayden, F. G., Mansour, H., Edwards, K., Newman, L. S., Asturias, E. J.
10.1101/2022.02.07.22270274 — Posted: 2022-02-08
A highly attenuated SARS-CoV-2 related pangolin coronavirus variant has a 104nt deletion at the 3'-terminus untranslated region
Lu, S., Luo, S., Liu, C., Li, M., An, X., Li, M., Hou, J., Fan, H., Mao, P., Tong, Y.-G., Song, L.
10.1101/2022.02.07.479352 — Posted: 2022-02-08
Spike Protein-independent Attenuation of SARS-CoV-2 Omicron Variant in Laboratory Mice
Liu, S., Selvaraj, P., Sangare, K., Luan, B., Wang, T. T.
10.1101/2022.02.08.479543 — Posted: 2022-02-08
Anti-spike antibody trajectories in individuals previously immunised with BNT162b2 or ChAdOx1 following a BNT162b2 booster dose
Yavlinsky, A., Beale, S., Nguyen, V., Shrotri, M., Byrne, T. E., Geismar, C., Fragaszy, E., Hoskins, S. J., Fong, W. L. E., Navaratnam, A. M. D., Braithwaite, I., Patel, P., Kovar, J., Hayward, A. C., Aldridge, R. W.
10.1101/2022.02.07.22270451 — Posted: 2022-02-08
Heterologous SARS-CoV-2 IgA neutralising antibody responses in convalescent plasma
Davis, S. K., Selva, K., Lopez, E., Haycroft, E., Lee, W. S., Wheatley, A. K., Juno, J. A., Adair, A., Pymm, P., Redmond, S., Gherardin, N., Godfrey, D., Tham, W.-H., Kent, S., Chung, A.
10.1101/2022.02.06.22270359 — Posted: 2022-02-08
History of SARS-CoV-2 infection, anti-spike IgG antibody kinetics and neutralization capacities following the second and third dose of BNT162b2 vaccine in nursing home residents
Jeulin, H., Labat, C., Duarte, K., Toupance, S., Nadin, G., Craus, D., Georgiopoulosh, I., Gantois, I., Goehringer, F., Benetos, A.
10.1101/2022.02.07.22270557 — Posted: 2022-02-08
Role of Covid vaccine in determining ICU admission and death due to Covid -19 in Tamil Nadu
T.S, S., Kumarasamy, P., subramaniam, s., A, S., P, S., Krishnamurthy, V. K.
10.1101/2022.02.07.22270596 — Posted: 2022-02-08 Discussion: Onsite
Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy: a multi-database, self-controlled case series study
Massari, M., Spila-Alegiani, S., Morciano, C., Spuri, M., Marchione, P., Felicetti, P., Belleudi, V., Poggi, F. R., Lazzeretti, M., Ercolanoni, M., Clagnan, E., Bovo, E., Trifiro, G., Moretti, U., Monaco, G., Leone, O., Da Cas, R., Petronzelli, F., Tartaglia, L., Mores, N., Zanoni, G., Rossi, P., Samez, S., Zappetti, C., Marra, A. R., Menniti-Ippolito, F.
10.1101/2022.02.07.22270020 — Posted: 2022-02-08
Genetic immune response and antibody repertoire of heterologous ChAdOx1-BNT162b2 vaccination in a Korean cohort
Lee, H. K., Go, J., Sung, H., Kim, S. W., Walter, M., Knabl, L., Furth, P. A., Hennighausen, L., Huh, J. W.
10.1101/2022.02.07.22270617 — Posted: 2022-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).